New Strong Buy Stocks for January 31st

Zacks Equity Research Published on January 31, 2024

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

ADMA Biologics, Inc. (ADMA - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.

Inhibikase Therapeutics, Inc. (IKT - Free Report) : This clinical-stage pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing nearly 16% over the last 60 days.

YPF Sociedad Anónima (YPF - Free Report) : This international energy company engaging in the integrated business of hydrocarbons has seen the Zacks Consensus Estimate for its current year earnings increasing 24.2% over the last 60 days.

Anavex Life Sciences Corp. (AVXL - Free Report) : This clinical stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 7% over the last 60 days.

Ekso Bionics Holdings, Inc. (EKSO - Free Report) : This exoskeleton products company has seen the Zacks Consensus Estimate for its current year earnings increasing 25.6% over the last 60 days.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Just Released: Zacks Top 10 Stocks for 2024

Hurry – you can still get in early on our 10 top tickers for 2024. Hand-picked by Zacks Director of Research, Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2023, the Zacks Top 10 Stocks gained +974.1%, nearly TRIPLING the S&P 500’s +340.1%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2024. You can still be among the first to see these just-released stocks with enormous potential.